Form of Product. Alexza shall deliver the Product to BLS in accordance with the Specifications in Baseline Package Form unless otherwise agreed by the Parties. If the Parties are required by any Regulatory Requirements or Regulatory Authority or BLS desires to make a change to the artwork or component artwork (a) in the U.S. following Marketing Approval in the Initial Indication and such change does not constitute a change to the Specifications, or (b) in Canada, then in each case BLS shall be [ * ] such change, including [ * ] if and to the extent such change also causes an [ * ] of Manufacturing the Product, as supported by documented evidence.
Form of Product. Long-Term Transmission Rights shall be issued in form of base load products with a fixed amount of MW over the product period.
Form of Product. Alexza shall deliver the Product to Teva in accordance with the Specifications in Prepackaged Form unless otherwise agreed by the Parties. Teva shall be responsible for any costs and expenses incurred in labeling the Product for use or sale in the U.S. If the Parties are required by any Regulatory Requirements or the FDA, or Teva [ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. desires to make a change to the artwork or component artwork in the U.S., following Regulatory Approval and such change does not constitute a change to the Specifications, then in each case Teva shall be responsible for the incremental costs and expenses incurred in implementing such change if and to the extent such change also causes an incremental change to the cost of manufacturing the Product, as supported by documented evidence.
Form of Product. Alexza shall deliver the Product to Teva in accordance with the Specifications in Prepackaged Form unless otherwise agreed by the Parties. Teva shall be responsible for any costs and expenses incurred in labeling the Product for use or sale in the U.S. If the Parties are required by any Regulatory Requirements or the FDA, or Teva desires to make a change to the artwork or component artwork in the U.S., following Regulatory Approval and such change does not constitute a change to the Specifications, then in each case Teva shall be responsible for the incremental costs and expenses incurred in implementing such change if and to the extent such change also causes an incremental change to the cost of manufacturing the Product, as supported by documented evidence. [ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Form of Product. Alexza shall deliver the Product to Xxxxxx in accordance with the Specifications in Bulk Form unless otherwise agreed by the Parties. The Product shall be delivered and released to Xxxxxx with at least [ * ] ([ * ]) months of shelf life remaining as of the time of delivery. The Parties have agreed that Alexza shall use commercially reasonable efforts to extend the shelf life beyond the initial [ * ] ([ * ]) month Product shelf life. If the Product shelf life has been extended to [ * ] ([ * ]) months or more, Alexza shall thereafter deliver the Product with at least [ * ] percent ([ * ]%) of the then current shelf life (rounded down to the [ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Form of Product. Unless otherwise agreed upon by the Parties, Product will be provided in powder form and delivered in sealed PE-HD (high-density polyethylene) cans.
